- Research works
- 24 ▲ 1472% vs 2013–17
- Citations
- 393 16.5 per fractional work
- Top-10% rate
- 11.6% record average 16.5%
- Open access
- 58% world 28%
Not ranked overall: Pfizer (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
Which keywords describe research at Pfizer (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Inflammatory Bowel Disease, Genetics, Immunology, Inflammation, Crohn's Disease and Ulcerative Colitis.
- Chemotherapy
- Diagnosis
- Sickle-cell Disease
- Ulcerative Colitis
- Immunology
- Inflammation
- Pathogenesis
- Epidemiology
- Inflammatory Bowel Disease
- Genetics
- Crohn's Disease
- Pulmonary Hypertension
- Thalassemia
- Treatment
- Management
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 15 words, with their numbers
- Epidemiology6▲ 6.7×21 topics
- Pathogenesis3▲ 25×7 topics
- Inflammatory Bowel Disease3▲ 116×4 topics
- Inflammation3▲ 4.8×13 topics
- Genetics2▲ 14×4 topics
- Immunology2▲ 87×3 topics
- Crohn's Disease2▲ 111×1 topic
- Ulcerative Colitis2▲ 253×1 topic
- Pulmonary Hypertension2▲ 51×2 topics
- Sickle-cell Disease2▲ 164×1 topic
- Thalassemia2▲ 164×1 topic
- Diagnosis2▲ 6.7×11 topics
- Treatment1▲ 4.3×8 topics
- Chemotherapy1▲ 6.7×12 topics
- Management1▲ 5.5×7 topics
Which research topics does Pfizer (Switzerland) publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Inflammatory Bowel Disease, Iron Metabolism and Disorders and Microscopic Colitis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 2 works
- 2 Inflammatory Bowel Disease Genetics 2 works
- 3 Iron Metabolism and Disorders Hematology 1 works
- 4 Microscopic Colitis Epidemiology 1 works
- 5 Liver Diseases and Immunity Hepatology 0 works
- 6 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
- 7 Helicobacter pylori-related gastroenterology studies Surgery 0 works
- 8 Spondyloarthritis Studies and Treatments Rheumatology 0 works
- 9 Health Services Management and Policy General Health Professions 0 works
- 10 Sphingolipid Metabolism and Signaling Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (Switzerland)'s research output changed?
Output in 2018–2022 was 1472% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zurich
- ETH Zurich
- University of Zurich
- University Hospital of Zurich
- Board of the Swiss Federal Institutes of Technology
- ABB (Switzerland)
- University Children's Hospital Zurich
- Zurich University of Applied Sciences in Business Administration
- Institute for Biomedical Engineering
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.